TITLE

Continuation of Medically Necessary Asprin and Warfarin During Cutaneous Surgery

AUTHOR(S)
Otley, Clark C.
PUB. DATE
November 2003
SOURCE
Mayo Clinic Proceedings;Nov2003, Vol. 78 Issue 11, p1392
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Excisional cutaneous surgery is performed commonly in patients who take medically necessary aspirin or warfarin. Although controversy has existed regarding the appropriate perioperative management of anticoagulant therapy during cutaneous surgery, recent data suggest that the risk of severe hemorrhagic complications is not increased if these medications are continued. Brief perioperative discontinuation does not lower this already minimal hemorrhagic risk. Furthermore, life-threatening thromboembolic complications have been related temporally to perioperative discontinuation of both aspirin and warfarin. In light of the absence of benefit and the presence of risks associated with discontinuation of warfarin and aspirin perioperatively during excisional cutaneous surgery, continuation of these medications is recommended in most situations. In all cases, the individual patient's medical history and risk factors should be taken into account when making this clinical decision, and deviation from the guidelines should be considered if clinical imperatives warrant.
ACCESSION #
11286413

 

Related Articles

  • Needle Electromyograph Hemorrhagic Risks and Complications. Rubin, Michael // Neurology Alert;Dec2008, Vol. 27 Issue 4, p30 

    IS THERE AN INCREASED RISK OF HEMATOMA FORMATION following needle electromyography (EMG) in patients on aspirin, clopidogrel, or warfarin? To address this question, adult patients undergoing EMG of the tibialis anterior muscle, as part of a routine lower extremity EMG, were enrolled in a...

  • Apixaban (Eliquis) for Stroke Prevention in Atrial Fibrillation. BECK, ROBERT A.; KING IV., WILLIAM M. // American Family Physician;4/15/2014, Vol. 89 Issue 8, p674 

    The article offers information on apixaban or Eliquis as an oral anticoagulant for stroke prevention in patients with atrial fibrillation. Topics discussed include the difference of apixaban from warfarin or Coumadin, the safety of taking apixaban, and its tolerability. Also mentioned are the...

  • dipyridamole. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p236 

    An encyclopedia entry for "dipyridamole" is presented. It is a drug that reduces the stickiness of platelets in the blood and thereby helps to prevent the formation of abnormal blood clots within arteries. It may be used with aspirin or warfarin to prevent the formation of blood clots following...

  • Warfarin vs Clopidogrel Plus Aspirin for Atrial Fibrillation. DiMarco, John P. // Clinical Cardiology Alert;Jan2008, Vol. 27 Issue 1, p4 

    The atrial fibrillation clopidogrel trial with Irbesartan for Prevention of Vascular Events (ACTIVE W) is a noninferiority trial comparing anticoagulation with warfarin to therapy with aspirin plus clopidogrel for stroke prevention in patients with atrial fibrillation. ACTIVE W enrolled 6706...

  • Herbal Remedy Interactions with Warfarin and Aspirin. O'Mathúna, Dónal // Alternative Medicine Alert;Jun2011, Vol. 14 Issue 6, p69 

    The article explores potential interactions between herbal remedies and anticoagulant medicines such as warfarin and aspirin. Herbs that are known to have an impact on the cytochrome P450 system in the liver, in which warfarin is metabolized, include Saint John's wort. Studies are cited that...

  • The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study. Burton, Chris; Isles, Chris; Norrie, John; Hanson, Ruth; Grubb, Elaine // British Journal of General Practice;Sep2006, Vol. 56 Issue 530, p697 

    Background Atrial fibrillation is a common problem in older people. The evidence base for the safety of warfarin and aspirin in atrial fibrillation is largely derived from selective research studies and secondary care. Further assessment of the safety of warfarin in older people with atrial...

  • The Cataract National Dataset electronic multicentre audit of 55 567 operations: antiplatelet and anticoagulant medications. Benzimra, J. D.; Johnston, R. L.; Jaycock, P.; Galloway, P. H.; Lambert, G.; Chung, A. K. K.; Eke, T.; Sparrow, J. M. // Eye;Jan2009, Vol. 23 Issue 1, p10 

    AimsThis study aims to establish the prevalence of aspirin, dipyridamole, clopidogrel, and warfarin use in patients undergoing cataract surgery, and to compare local anaesthetic and intraoperative complication rates between users and non-users.MethodsThe Cataract National Dataset was remotely...

  • RESEARCH DIGEST: Warfarin best at stroke prevention in AF. Kaplan, Deborah // Patient Care for the Nurse Practitioner;Aug2006, Vol. 9 Issue 8, p2 

    The article discusses a study on anticoagulant warfarin, which has been used in patients with atrial fibrillation and is considered as the gold-standard treatment for preventing stroke. In the study "Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events," 6,706...

  • Choosing Between Warfarin (Coumadin) and Aspirin Therapy for Patients with Atrial Fibrillation. Ebell, Mark H. // American Family Physician;6/15/2005, Vol. 71 Issue 12, p2348 

    Presents the results of a case study which compared the effect of warfarin with aspirin treatment for patients with atrial fibrillation. Possibility of stroke in a patient with nonvalvular atrial fibrillation; Risk factors associated with warfarin use; Clinical guidelines for evaluating the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics